The use of botulinum toxin in the treatment of bruxism
DOI:
https://doi.org/10.33448/rsd-v11i4.27304Keywords:
Bruxims; Partnership practice dental; Botulinum toxins type A.Abstract
The objective of this study was to review the literature regarding the use of botulinum toxin in the treatment of bruxism. The bruxism, contact static or dynamic of the teeth, at times other than those that occur during normal functions of chewing or swallowing, is always associated with an emotional state changes of the patient, i.e., the stress. This habit parfunctional constitutes one of the most difficult challenges to restorative dentistry and, in some cases, produces reflections in the periodontium, in the masticatory muscles, in the temporomandibular joint. You can also cause headache, behavioral effects and psychological, and it is very difficult to its resolution, depending on the severity of the wear produced. How to treat the Botulinum toxin type A has been used in patients who suffer from erectile dysfunction, because it is a less invasive alternative and which demonstrates good therapeutic results.
References
Al-Wayli, H. (2017). Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study. Journal of clinical and experimental dentistry, 9(1), e112.
Amantéa, D. V., Novaes, A. P., Campolongo, G. D., & Pessoa de Barros, T. (2003). A utilização da toxina botulínica tipo A na dor e disfunção temporomandibular. JBA, 3(10), 170-173.
Arellano Flores, A., & Picco Díaz, I. (2008). Toxina botulínica en la distonía muscular de la articulación temporomandibular. Revista odontológica mexicana, 12(3), 142-148.
Attanasio, R. (1997). An overview of bruxism and its management. Dental Clinics of North America, 41(2), 229-241.
Benini, G. T. (2020). O uso da toxina botulínica no tratamento da DTM muscular.
Bhidayasiri, R., Cardoso, F., & Truong, D. (2006). Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations. European journal of neurology, 13, 21-29.
Bicalho, M. B. D., Fernanda Pereira. (2015). Toxina botulínica no tratamento da disfunção temporomandibular. Políticas e Saúde Coletiva, 1(2).
Canales, G. T., Alvarez-Pinzon, N., Muñoz-Lora, V. R. M., Vieira Peroni, L., Farias Gomes, A., Sánchez-Ayala, A., & Rizzatti-Barbosa, C. M. (2020). Efficacy and safety of botulinum toxin type a on persistent myofascial pain: a randomized clinical trial. Toxins, 12(6), 395.
Chaudhary, G., Jairath, R., Chaudhary, N., Chaudhary, A., Bector, K., & Chaudhary, G. (2016). Rejuvenated Smile with Botox: Opening a new Frontier. Annals of Prosthodontics & Restorative Dentistry, 2(2), 37-41.
De La Torre Canales; Kumar, A., & Spivakovsky, S. (2018). Bruxism-is botulinum toxin an effective treatment? Evidence-based dentistry, 19(2), 59-59.
Fernández-Núñez, T., Amghar-Maach, S., & Gay-Escoda, C. (2019). Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Medicina oral, patologia oral y cirugia bucal, 24(4), e416.
Freund, B., Schwartz, M., & Symington, J. M. (1999). The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. Journal of oral and maxillofacial surgery, 57(8), 916-920.
Long, H., Liao, Z., Wang, Y., Liao, L., & Lai, W. (2012). Efficacy of botulinum toxins on bruxism: an evidence-based review. International dental journal, 62(1), 1-5.
Maciel, R. (1996). Tratamento. Maciel RN. Oclusão e ATM: Procedimentos Clínicos. Santos, 259-342.
Manfredini, D., Ahlberg, J., Winocur, E., & Lobbezoo, F. (2015). Management of sleep bruxism in adults: a qualitative systematic literature review. Journal of oral rehabilitation, 42(11), 862-874.
Okeson, J. P. (1992). Fundamentos de oclusão e desordens têmporo-mandibulares: Artes médicas.
Ondo, W. G., Simmons, J. H., Shahid, M. H., Hashem, V., Hunter, C., & Jankovic, J. (2018). Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study. Neurology, 90(7), e559-e564.
Pascotto, R. C., & Moreira, M. (2005). Integração da odontologia com a medicina estética: correção do sorriso gengival. RGO, 171-175.
Pedron, I. G. (2014). Aplicação da toxina botulínica associada à clínica integrada no tratamento do sorriso gengival. J Health Sci Inst, 32(4), 365-369.
Quezada-Gaon, N., Wortsman, X., Peñaloza, O., & Carrasco, J. E. (2016). Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects. J Cosmet Dermatol, 15(3), 238-244. doi:10.1111/jocd.12208
Redaelli, A. (2011). Botulinum Toxin A in bruxers. One year experience. Saudi Med J, 32(2), 156-158.
RN, M. (2010). Hipóteses etiólicas. Maciel RN. Bruxismo. Artes Médicas, 5-42.
Soares, C. B., et al. (2014). Revisão integrativa: conceitos e métodos utilizados na enfermagem. Revista da Escola de Enfermagem da USP, 48(2), 335-345.
Scott, A. B. (1980). Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology, 87(10), 1044-1049.
Scott, A. B., Rosenbaum, A., & Collins, C. C. (1973). Pharmacologic weakening of extraocular muscles. Investigative Ophthalmology & Visual Science, 12(12), 924-927.
Shim, Y. J., Lee, M. K., Kato, T., Park, H. U., Heo, K., & Kim, S. T. (2014). Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation. J Clin Sleep Med, 10(3), 291-298. doi:10.5664/jcsm.3532
Sposito, M. M. d. M., & Teixeira, S. A. F. (2014). Toxina Botulínica Tipo A para bruxismo: analise sistemática. CEP, 5716, 150.
Tan, E. K., & Jankovic, J. (2000). Treating severe bruxism with botulinum toxin. J Am Dent Assoc, 131(2), 211-216. doi:10.14219/jada.archive.2000.0149
Teixeira, S. A. F., & de Mello Sposito, M. M. (2014). A utilização de Toxina Onabotulínica A para bruxismo: Revisão de Literatura. Revista Brasileira de Odontologia, 70(2), 202.
Ventura, M. d. L. A. (2021). Uso da toxina botulínica tipo A e placa intra-oral modificada com levantamento anterior no controle do bruxismo – relato de caso clínico.
Von Lindern, J. (2001). Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction. Acta neurologica Belgica, 101(1), 39-41.
Wheeler, A. H., Goolkasian, P., & Gretz, S. S. (1998). A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine (Phila Pa 1976), 23(15), 1662-1666; discussion 1667. doi:10.1097/00007632-199808010-00009
Zuanon, A., Campos, C., Giro, E., & Pansani, C. (1999). Bruxismo infantil. Odontol Clin, 9, 41-44.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Fernanda Rabelo Cunha; Daniela Bezerra de Menezes Borba; Ricardo Cesar Gobbi de Oliveira; Renata Cristina Oliveira; Fabrício Pineli Valarelli; Karina Maria Salvatore Freitas; Paula Cotrin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
